Frederick L. Ruberg, MD, FACC

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Eidos Therapeutics(SIGNIFICANT), Pfizer, Inc.(SIGNIFICANT), Akcea Therapeutics(SIGNIFICANT), Alnylam Pharmaceuticals(SIGNIFICANT), Pfizer, Inc.(SIGNIFICANT)

View Full Disclosure